Last updated: September 11, 2026
[Key Takeaways]
- The share of women ages 21-29 who report never having had a cervical cancer screening test rose from about 12.5% in 2005 to about 32% (nearly a third) in 2023.
- Screening gaps among women ages 30-65 also rose substantially over the same period — from about 5.3% in 2005 to nearly 15% in 2023 — though the increase was smaller than among women ages 21-29.
- Asian women ages 21-29 report the highest unscreened rate among racial and ethnic groups studied, at roughly 44%, compared with about 29% among white women in the same age group.
- Breast and colorectal cancer screening rates largely recovered after pandemic-related disruptions, but cervical cancer screening among young adults has not returned to pre-pandemic levels.
- Current guidelines and low-cost screening options for women without regular access to a primary care provider are outlined later in this article.
It is written in the hope that it can be of even a little help to many readers.
Overview
Cervical cancer is considered one of the more preventable cancers when routine screening and follow-up care are in place, yet a growing share of young women in the United States are going without the tests that make early detection possible.[1] New research tracking screening behavior over nearly two decades points to a clear pattern: the rise in unscreened rates has been sharpest among women ages 21-29, though screening gaps among women ages 30-65 have also grown substantially over the same period, just not as steeply.[1] Understanding why this younger cohort is falling behind — and what to do about it — is the focus of this article.
Table of Contents
What the Data Shows: Cervical Cancer Screening Among Women 21-29
An analysis of national screening survey data found that the proportion of women ages 21-29 who reported never having been screened for cervical cancer climbed from about 12.5% in 2005 to nearly a third (about 32%) in 2023.[1] That is a more than twofold increase in under-screening within a single generation. By contrast, women ages 30-65 — who are typically further along in establishing regular care with an OB-GYN or primary care provider — also saw their unscreened rate rise substantially over the same stretch, from about 5.3% in 2005 to nearly 15% in 2023, though the increase was smaller than among women in their twenties.[1]
The trend is also notable in how it compares with other routine cancer screenings. Mammography and colorectal cancer screening rates dipped sharply during the COVID-19 pandemic, as many people delayed non-urgent preventive visits, but both have since rebounded close to pre-pandemic levels.[1] Cervical cancer screening among young women is the exception — rates have not recovered and instead appear to be continuing a longer downward trend that predates the pandemic.[1]
[1] Star et al., "Cancer Screening 3 Years After the Onset of the COVID-19 Pandemic," JAMA (2025)
Racial and Ethnic Disparities in Screening Rates
The decline is not evenly distributed across racial and ethnic groups. Among women ages 21-29, Asian women reported the highest rate of never having been screened, at approximately 44%, compared with about 29% among white women in the same age range.[1] Researchers have pointed to a combination of factors that may contribute to this gap, including differences in insurance coverage, cultural attitudes toward pelvic exams, language barriers in clinical settings, and lower rates of established primary care relationships among some immigrant and first-generation communities.[1] More research is needed to fully explain the size of this disparity.
Why Are Young Women Skipping Cervical Cancer Screening?
Public health researchers have proposed several overlapping explanations for why this specific age group has fallen behind, ranging from structural barriers in the health system to shifting attitudes shaped by the HPV vaccine.
Access and Cost Barriers
Women in their twenties are more likely than older adults to be uninsured or underinsured, to be transitioning between jobs or off a parent's insurance plan, and to lack an established primary care provider.[1] Without a regular point of contact in the health system, a routine screening that would otherwise be scheduled as part of an annual visit may simply never come up. Cost-sharing for the exam itself, time off work, and lack of transportation or childcare can compound the problem, particularly for women in lower-income households.[1]
[1] KFF, "Uninsured Young Adults: A Profile and Overview of Coverage Options"
Misplaced Confidence From the HPV Vaccine
Many women now in their twenties were among the first cohorts to receive the HPV vaccine as adolescents. It's possible that, for some, this contributed to a mistaken assumption that screening is no longer necessary once vaccinated. The HPV vaccine is associated with a substantial reduction in the risk of infection from the high-risk HPV types it targets, but it may not fully protect against every strain linked to cervical cancer, and it offers no benefit against infections that occurred before vaccination.[1] Current guidance continues to recommend routine screening for vaccinated and unvaccinated women alike, though this message does not always appear to be reaching younger patients clearly.[2]
[1] NCI, "Human Papillomavirus (HPV) Vaccine" Fact Sheet
[2] Curry et al., "Screening for Cervical Cancer: USPSTF Recommendation Statement," JAMA (2018); Fontham et al., CA Cancer J Clin (2020); Perkins et al., CA Cancer J Clin (2026)
Lingering Pandemic Disruption
The COVID-19 pandemic led many clinics to postpone non-urgent preventive services in 2020, and some young women who missed a screening during that period may not have rescheduled once routine care resumed.[1] It's also possible that cervical cancer screening in this age group is more easily deprioritized once an appointment is missed, compared with mammography and colorectal screening, which are often tied to more structured reminder systems and a higher perceived sense of urgency.
[1] Star et al., "Cancer Screening 3 Years After the Onset of the COVID-19 Pandemic," JAMA (2025)
Distrust in the Healthcare System and Exam Discomfort
Surveys of young adults have identified discomfort with pelvic exams, embarrassment, and prior negative experiences with providers as recurring reasons for avoiding screening.[1] Broader distrust in the healthcare system — including concerns about being dismissed, judged, or not listened to during a sensitive exam — has also been cited, particularly among Black women and other patients from historically underserved communities.[2] These concerns are increasingly being addressed through newer options such as self-collection HPV testing, discussed later in this article, which may reduce some of the discomfort associated with a traditional pelvic exam.
[1] "The Clinical Impact of Patient Embarrassment in Gynecology," Medical Sciences (Basel) (2026)
[2] Haro et al., "Barriers to Cervical Cancer Screening... Among Black Women in Michigan," Medical Research Archives (2024)
Why This Matters: Screening Gaps and Advanced-Stage Diagnoses
Routine screening is designed to catch precancerous changes to the cervix before they progress. A South Korean cohort study found that regular Pap testing was associated with improved long-term survival among cervical cancer patients, underscoring why consistent screening matters.[1] When screening gaps widen, some researchers have observed a corresponding increase in cervical cancer cases diagnosed at a later, more advanced stage — particularly in the 30-64 age group — when treatment options may be more limited.[2] This pattern may be linked to — rather than definitively caused by — the drop in screening among younger women, and researchers continue to study the relationship between the two trends.[2]
[1] Luu et al., "Effect of Pap smears on the long-term survival of cervical cancer patients," Epidemiology and Health (2022)
[2] Francoeur et al., "The increasing incidence of stage IV cervical cancer in the USA," Int J Gynecol Cancer (2022)
※ If you experience unusual vaginal bleeding, bleeding after intercourse, unusual discharge, or persistent pelvic pain, it is advisable to contact a healthcare provider promptly rather than waiting for a scheduled screening. These symptoms do not necessarily indicate cervical cancer, but they warrant timely evaluation.
How Often Should You Be Screened?
Screening recommendations vary by age and are periodically updated by organizations such as the American Cancer Society (ACS) and the U.S. Preventive Services Task Force (USPSTF). The table below reflects generally recognized guidance; readers should confirm current recommendations with a healthcare provider, as intervals can vary based on individual risk factors and prior test results.
| Age Group | Recommended Test | Suggested Frequency |
|---|---|---|
| Ages 21-29 | Pap test (cytology) alone | Every 3 years |
| Ages 30-65 | HPV test alone, HPV/Pap co-testing, or Pap test alone | Every 5 years (HPV-based testing) or every 3 years (Pap alone) |
| Ages 65 and older | May be discontinued with adequate prior screening history | Discuss individual eligibility with a provider |
These intervals are not identical across organizations. The USPSTF recommends starting cervical cancer screening at age 21 with Pap testing alone, repeated every three years, through age 65.[1] The American Cancer Society's updated guideline instead recommends starting at age 25, with primary HPV testing on its own identified as the preferred method; a Pap test alone is presented as an acceptable alternative only where HPV testing is not available.[2] For ages 30-65, both organizations recognize HPV-based testing every five years or Pap testing alone every three years as appropriate options, and both support discontinuing screening after age 65 for individuals with an adequate history of prior negative results.[1][2]
[1] Curry et al., "Screening for Cervical Cancer: USPSTF Recommendation Statement," JAMA (2018)
[2] Fontham et al., CA Cancer J Clin (2020); Perkins et al., CA Cancer J Clin (2026)
These intervals apply to women at average risk. Women with a history of abnormal results, a weakened immune system, or other risk factors may be advised to follow a more frequent schedule.[1]
[1] Curry et al., JAMA (2018); Fontham et al., CA Cancer J Clin (2020)
How to Get Screened: Practical Steps and Low-Cost Options
For women who have an existing OB-GYN or primary care provider, scheduling a screening typically starts with a call or online booking request for an annual well-woman visit, during which a Pap test, HPV test, or both can usually be performed. Women who are between providers or recently changed insurance can ask a new primary care office whether cervical cancer screening can be included at an initial visit.
For those without insurance or a regular provider, several lower-cost options exist across the country:
- Title X-funded family planning clinics offer cervical cancer screening on a sliding fee scale based on income, and some offer services at no cost to eligible patients.[1]
- Planned Parenthood health centers provide Pap tests and HPV testing and may offer sliding-scale pricing for patients without insurance.
- Federally Qualified Health Centers (FQHCs), found in most counties, offer primary and preventive care regardless of ability to pay.
- The CDC's National Breast and Cervical Cancer Early Detection Program provides free or low-cost screening to eligible low-income, uninsured, and underinsured women in every state.[2]
- Self-collection HPV testing, in which a patient collects their own vaginal sample rather than undergoing a traditional speculum exam, has become more widely available in clinical settings and may be a useful option for women who have avoided screening due to discomfort with pelvic exams.[3] This approach is not yet universally available, so it is worth asking a clinic directly whether it is offered.
[1] HHS Office of Population Affairs, "Title X Family Planning Program Overview"
[2] CDC, "About the National Breast and Cervical Cancer Early Detection Program"
[3] Perkins et al., CA Cancer J Clin (2026); NCI Cancer Currents, "FDA Approves HPV Test With Self-Collection"
Women who are uncertain about their own screening history can also request records from a previous provider or ask a new clinic to help reconstruct their screening timeline before deciding on next steps.
References
- Sonawane K, Damgacioglu H, Amboree TL, et al. "Rates of Never Receiving Cervical Cancer Screening Among US Women, 2005-2023." JAMA Network Open. 9(8):e2631550 (2026). https://doi.org/10.1001/jamanetworkopen.2026.31550
- Star J, Han X, Smith RA, Schafer EJ, Jemal A, Bandi P. "Cancer Screening 3 Years After the Onset of the COVID-19 Pandemic." JAMA (2025). https://doi.org/10.1001/jama.2025.0902
- Francoeur AA, et al. "The increasing incidence of stage IV cervical cancer in the USA: what factors are related?" Int J Gynecol Cancer (2022). https://doi.org/10.1136/ijgc-2022-003728
- Luu XQ, Lee K, Jun JK, Suh M, Jung KW, Lim MC, Choi KS. "Effect of Pap smears on the long-term survival of cervical cancer patients: a nationwide population-based cohort study in Korea." Epidemiology and Health. 44:e2022072 (2022). https://doi.org/10.4178/epih.e2022072
- Curry SJ, et al. "Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement." JAMA. 320(7):674-686 (2018). https://pubmed.ncbi.nlm.nih.gov/30140884/
- Fontham ETH, et al. "Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society." CA Cancer J Clin. 70(5):321-346 (2020). https://pubmed.ncbi.nlm.nih.gov/32729638/
- Perkins RB, et al. "Self-collected vaginal specimens for human papillomavirus testing and guidance on screening exit: An update to the American Cancer Society cervical cancer screening guideline." CA Cancer J Clin. 76 (2026). https://doi.org/10.3322/caac.70041
- Haro E, Butcher EA, Alves ML, El Khoury C, Vinson A, Harper DM. "Barriers to Cervical Cancer Screening and Satisfaction with Self-Sampling among Black Women in Michigan: A Mixed Methods Study." Medical Research Archives. 12(4) (2024). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11138408/
- "The Clinical Impact of Patient Embarrassment in Gynecology: A Comprehensive Review of Barriers, Consequences, and Mitigation Strategies." Medical Sciences (Basel). 14(2):335 (2026). https://doi.org/10.3390/medsci14020335
- CDC. "About the National Breast and Cervical Cancer Early Detection Program." https://www.cdc.gov/breast-cervical-cancer-screening/about/
- HHS Office of Population Affairs. "Title X Family Planning Program Overview." https://opa.hhs.gov/sites/default/files/2022-12/title-x-family-planning-program-2022.pdf
- National Cancer Institute (NCI). "Human Papillomavirus (HPV) Vaccine" Fact Sheet. https://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-vaccine-fact-sheet
- NCI Cancer Currents. "FDA Approves HPV Test With Self-Collection in a Health Care Setting." https://www.cancer.gov/news-events/cancer-currents-blog/2024/fda-hpv-test-self-collection-health-care-setting
- KFF. "Uninsured Young Adults: A Profile and Overview of Coverage Options." https://www.kff.org/affordable-care-act/uninsured-young-adults-a-profile-and-overview/
Comments
Post a Comment